Sunday, 19 April 2026 06:16 PM EDT
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reported on Sunday.
Reuters could not immediately verify the report.
© 2026 Thomson/Reuters. All rights reserved.
Receive breaking news and original analysis - sent right to your inbox.
Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.